Akums Drugs & Pharmaceuticals Share Price Jumps to Fresh 52-Week High at Rs 826: Here’s Why

Published: 21 September 2026 at 9:48 AM IST

Akums Drugs & Pharmaceuticals Share Price moved to Rs 822.95 on 21 September 2026, up 4.97% from the previous close of Rs 783.95, and marked a fresh 52-week high at Rs 825.95. The company’s market capitalisation is Rs 12,338.90 crore. The price event is relevant because the stock opened at Rs 783.95, traded between Rs 782.85 and Rs 825.95, and ended near the day’s high. The supplied data confirms the price event; it does not establish a company-specific catalyst. For readers tracking Akums Drugs & Pharmaceuticals Stock News, this is a clear market update to note alongside valuation, sector comparison and company fundamentals. Univest is following the move with a focus on verified numbers rather than assumptions.

Akums Drugs & Pharmaceuticals Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 822.95
Previous Close	Rs 783.95
Today's Move	+Rs 39 (+4.97%)
Open	Rs 783.95
High	Rs 825.95
Low	Rs 782.85
Turnover	Rs 1.65 crore
Market Capitalisation	Rs 12,338.9 crore

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) traded at Rs 822.95 versus the previous close of Rs 783.95, a rise of 4.97%. The stock opened at Rs 783.95, reached a high of Rs 825.95 and touched a low of Rs 782.85.

Akums Drugs & Pharmaceuticals Share Price Today shows a Rs 39.00 gain over the previous close, with the stock closing at Rs 822.95 after opening at Rs 783.95. The day’s low was Rs 782.85 and the day’s high was Rs 825.95, which also stands as the fresh 52-week high. That means the stock finished very close to the intraday top and only Rs 3.00 below the peak seen during the session. Turnover stood at Rs 1.65 crore. From a pure price-action perspective, the move reflects a completed yearly high on verified data, and Akums Drugs & Pharmaceuticals Share Price continues to be the main search focus for investors following Akums Drugs & Pharmaceuticals Stock News and Akums Drugs & Pharmaceuticals Share Price Live updates. Univest notes the event as a factual market milestone, not as a forecast. Akums Drugs & Pharmaceuticals Share Price now enters a new reference point for year-on-year comparison.

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 12,338.9 crore
P/E Ratio	42.3x
P/B Ratio	3.61x
ROE	8.06%
ROCE	14.77%
EPS	Rs 18.53
Book Value Per Share	Rs 216.98
Dividend Yield	0.38%

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) fundamental metrics show P/E 42.3x, P/B 3.61x, ROE 8.06%, ROCE 14.77%. These figures provide context only and are not a buy or sell signal.

Akums Drugs & Pharmaceuticals Ltd. has a market capitalisation of Rs 12338.9 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 42.3x, P/B at 3.61x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 8.06% and ROCE of 14.77%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 18.53, book value per share of Rs 216.98, dividend yield of 0.38%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.18x, median ROE of 11.7%, median ROCE of 13.32%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	42.3x
Benchmark Median P/E	32.18x
Benchmark Average P/E	48.81x
Benchmark P/E Range	3.4x to 683.5x
Company P/B Ratio	3.61x
Benchmark Median P/B	3.04x
Company ROE	8.06%
Benchmark Median ROE	11.7%
Company ROCE	14.77%
Benchmark Median ROCE	13.32%
Company Market Capitalisation	Rs 12,338.9 crore
Benchmark Median Market Cap	Rs 677.56 crore

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a P/E ratio of 42.3x, which is above the benchmark median of 32.18x, a difference of +31.45%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a ROE of 8.06%, which is below the benchmark median of 11.7%, a difference of -31.11%. Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a ROCE of 14.77%, which is above the benchmark median of 13.32%, a difference of +10.89%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sudeep Pharma Ltd.	SUDEEPPHRM	13,045	71.43	14.12	25.37	28.5
CORONA Remedies Ltd.	CORONA	13,447.57	67.57	16.66	27.36	31.74
Strides Pharma Science Ltd.	STAR	11,245.07	18.33	3.43	20.31	18.57
Sequent Scientific Ltd.	VIYASH	11,036.28	64.48	3.92	9.06	13.1
Blue Jet Healthcare Ltd.	BLUEJET	10,887.14	46.35	4.86	19.88	27.18

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a P/E ratio of 42.3x compared with the displayed peer median of 64.48x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.06% compares with a peer median of 20.31% across the companies shown in the table. ROCE stood at 14.77% versus the displayed peer median of 27.18%, providing a capital-efficiency comparison. Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a market capitalisation of Rs 12,338.9 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Akums Drugs & Pharmaceuticals

• Akums Drugs & Pharmaceuticals Share Price hit a fresh 52-week high of Rs 825.95.
• The stock closed at Rs 822.95 after a 4.97% rise from the previous close.
• Market capitalisation is Rs 12,338.90 crore.
• P/E is 42.3 and P/B is 3.61, with EPS at Rs 18.53 and book value at Rs 216.98.
• The company’s ROCE of 14.77% is above the sector benchmark median of 13.32%.

About Akums Drugs & Pharmaceuticals

Akums Drugs & Pharmaceuticals Ltd. is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data identifies the company through its listed market details on NSE and BSE, with current attention centred on Akums Drugs & Pharmaceuticals Share Price and the fresh 52-week high event. Univest presents the stock within its verified industry classification, market capitalisation, valuation and financial ratios, keeping the focus on factual company data and price movement rather than assumptions about business drivers.

Track Akums Drugs & Pharmaceuticals Share Price on Univest

Use Akums Drugs & Pharmaceuticals Ltd. (AKUMS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track Akums Drugs & Pharmaceuticals Share Price on Univest for live price updates, sector context, valuation ratios, shareholding pattern when available, 52-week levels and company news. Univest brings Akums Drugs & Pharmaceuticals Share Price Today, Akums Drugs & Pharmaceuticals Stock News and Akums Drugs & Pharmaceuticals Share Price Update into one place for quick monitoring.

Frequently Asked Questions

What is Akums Drugs & Pharmaceuticals Share Price today?

Ans. Akums Drugs & Pharmaceuticals Share Price today is Rs 822.95, up 4.97% from the previous close of Rs 783.95. The stock also touched a fresh 52-week high of Rs 825.95 during the session.

Did Akums Drugs & Pharmaceuticals hit a fresh 52-week high?

Ans. Yes. Akums Drugs & Pharmaceuticals Share Price reached a fresh 52-week high of Rs 825.95. The close at Rs 822.95 kept the stock very near the session peak, based on the supplied market data.

What was the day’s movement in Akums Drugs & Pharmaceuticals Share Price?

Ans. The share price rose by Rs 39.00, or 4.97%, versus the previous close. The day’s open was Rs 783.95, the low was Rs 782.85 and the high was Rs 825.95.

What is the market capitalisation of Akums Drugs & Pharmaceuticals?

Ans. Akums Drugs & Pharmaceuticals has a market capitalisation of Rs 12,338.90 crore. Market capitalisation reflects company size in the market and helps place Akums Drugs & Pharmaceuticals Share Price in context.

How is Akums Drugs & Pharmaceuticals valued?

Ans. The stock trades at a P/E of 42.3 and a P/B of 3.61. EPS is Rs 18.53 and book value is Rs 216.98 per share, which together frame the valuation picture.

What do ROE and ROCE show for Akums Drugs & Pharmaceuticals?

Ans. ROE is 8.06% and ROCE is 14.77%. ROE measures return on shareholder equity, while ROCE measures capital efficiency, both of which add context to Akums Drugs & Pharmaceuticals Share Price.

How does Akums Drugs & Pharmaceuticals compare with sector benchmarks?

Ans. In the same-industry benchmark, the stock’s P/E of 42.3 is above the median of 32.18, and its ROCE of 14.77% is above the median of 13.32%. The comparison is mixed across ratios.

How does Akums Drugs & Pharmaceuticals compare with peers?

Ans. Among the supplied peers, Akums Drugs & Pharmaceuticals has a market capitalisation near Sudeep Pharma and CORONA Remedies. Its P/E is below several peers, while its ROE is lower than all five listed peers.

What is the book value and dividend yield for Akums Drugs & Pharmaceuticals?

Ans. Book value is Rs 216.98 per share and dividend yield is 0.38%. These figures help readers compare accounting value and historical payout context with the current Akums Drugs & Pharmaceuticals Share Price.

Where can I track Akums Drugs & Pharmaceuticals Share Price?

Ans. Readers can track Akums Drugs & Pharmaceuticals Share Price on Univest for live updates, valuation ratios, 52-week levels, company news and sector context. The same page also helps follow Akums Drugs & Pharmaceuticals Stock News.